Skip to main content

Table 6 Multivariable Cox regression analysis of factors associated with survival of patients

From: Perioperative chemotherapy versus adjuvant chemotherapy treatment for resectable locally advanced gastric cancer: a retrospective cohort study

Variable

OS

DFS

Multivariable analysis

HR (95% CI)

P-value

HR (95% CI)

P-value

Pre-therapy tumor size (cm)

    

 ≥ 5 vs. < 5

2.091 (1.176–3.715)

0.012

1.821 (1.050–3.156)

0.033

Clinical TNM stage

    

III/IVA vs. IIA/IIB

1.488 (0.611–2.436)

0.275

1.628 (0.925–2.864)

0.091

NAC

    

Yes vs. no

0.245 (0.103–0.811)

0.039

0.591 (0.364–0.958)

0.031

Histological grade

    

Poorly vs. well/moderate

-

-

1.905 (1.125–3.328)

0.046

Pathological T stage

    

T3/4a/4b vs. T0/1/2

2.266 (0.997–3.124)

0.027

1.607 (0.974–2.652)

0.063

Pathological N stage

    

N-positive vs. N-negative

1.111 (0.677–1.821)

0.677

1.109 (0.599–2.052)

0.742

Lymphovascular invasion

    

Yes vs. no

1.372 (0.917–1.821)

0.531

1.984 (1.254–2.796)

0.025

Pathological TNM stage

    

III/IV vs. 0/I/II

1.992 (1.062–3.736)

0.012

2.233 (1.198–4.162)

0.011

  1. OS overall survival; DFS disease-free survival; HR hazard ratio; CI confidence interval; NAC, neoadjuvant chemotherapy